Related Experiment Video
Updated: Mar 11, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Life-threatening Wunderlich's syndrome with concurrent clopidogrel use
Ned Kinnear1, Derek Barrry Hennessey1, Hannah Douglass-Molloy2
1Austin Hospital, Heidelberg, Victoria, Australia.
Wunderlich's syndrome, a rare cause of kidney bleeding, can be life-threatening. This case shows successful treatment of spontaneous renal hemorrhage in a patient on clopidogrel using angioembolization and coil placement.
Area of Science:
- Nephrology
- Vascular Surgery
- Interventional Radiology
Background:
- Spontaneous non-traumatic renal hemorrhage, or Wunderlich's syndrome, is a rare clinical presentation.
- This condition can lead to significant morbidity and mortality if not managed promptly.
- Antiplatelet medications like clopidogrel may increase the risk of bleeding events.
Observation:
- A 63-year-old male patient on clopidogrel presented with hemodynamic instability.
- The patient was diagnosed with spontaneous non-traumatic renal hemorrhage.
- Imaging revealed active bleeding from multiple distinct subsegmental renal vessels.
Findings:
- Angioembolization was performed to identify and treat the source of bleeding.
- Successful hemostasis was achieved through the placement of coils in the affected vessels.
- The patient's hemodynamic status stabilized post-procedure.
Implications:
- This case highlights the successful endovascular management of a rare and potentially fatal condition.
- Angioembolization with coil placement is an effective minimally invasive treatment for spontaneous renal hemorrhage.
- Maintaining near-normal renal function post-intervention is achievable.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Venous Thrombosis III: Interprofessional Care
Drug Toxicity: Risk factors

